TY  - GEN
AU  - Cheng,Xiaojing
AU  - Fan,Kelong
AU  - Wang,Lin
AU  - Ying,Xiangji
AU  - Sanders,Andrew J
AU  - Guo,Ting
AU  - Xing,Xiaofang
AU  - Zhou,Meng
AU  - Du,Hong
AU  - Hu,Ying
AU  - Ding,Huirong
AU  - Li,Ziyu
AU  - Wen,Xianzi
AU  - Jiang,Wenguo
AU  - Yan,Xiyun
AU  - Ji,Jiafu
TI  - TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer
SN  - 2041-4889
PY  - 2021///0309
KW  - Animals
KW  - Antibiotics, Antineoplastic
KW  - chemistry
KW  - Antigens, CD
KW  - genetics
KW  - Apoferritins
KW  - Biomarkers, Tumor
KW  - Cell Line, Tumor
KW  - Doxorubicin
KW  - Drug Carriers
KW  - Drug Compounding
KW  - Female
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - Male
KW  - Mice, Inbred NOD
KW  - Mice, SCID
KW  - Middle Aged
KW  - Nanoparticles
KW  - Neoplasm Transplantation
KW  - Receptors, Transferrin
KW  - Signal Transduction
KW  - Stomach Neoplasms
KW  - drug therapy
KW  - Theranostic Nanomedicine
KW  - Tumor Burden
KW  - drug effects
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/s41419-020-2272-z
ER  -